Although the three-dimensional structures of mouse and Torpedo californica acetylcholinesterase are very similar, their responses to the covalent sulfonylating agents benzenesulfonyl fluoride and phenylmethylsulfonyl fluoride are qualitatively different.
Introduction:
The principal biological role of acetylcholinesterase (AChE) is termination of transmission at cholinergic synapses by rapid hydrolysis of the neurotransmitter, acetylcholine (ACh) [1, 2] .
The crystal structure of TcAChE revealed that, despite the high catalytic activity of AChE, which approaches diffusion control [3] , its active site is near the bottom of a long and narrow gorge, >15 Å long, a large part of the surface of which is lined by aromatic residues [4] . Near the mid-point of the gorge is a bottleneck, between two conserved aromatic residues, whose cross-section is smaller than the diameter of the quaternary group of ACh, 6.4 Å. Thus, in TcAChE, the cross-section at the narrowest point of the bottleneck is ~5 Å [4] . In mAChE, the narrowest point of the bottleneck has a cross-section of 2.4 Å [5] . Space-filling representations of two ACh molecules are seen, one lodged above the gorge, and one below it [6] . This representation clearly illustrates that the AChE molecule needs to 'breathe' substantially in order for the ACh molecule to pass through the bottleneck to reach the active site.
AChE is the target of a repertoire of inhibitors that act by covalent modification of its active-site serine. These include organophosphate (OP) nerve agents, and both OP and carbamate insecticides [7] . Phenylmethylsulfonyl fluoride (PMSF) is a sulfonylating agent commonly employed as a non-specific inhibitor of serine proteases [8] . It was reported by Fahrney & Gold [9] that Electrophorus electricus AChE is resistant to inhibition by PMSF, 4 although it was later reported that it is indeed inhibited, but extremely slowly [10] . It was subsequently shown that mammalian AChEs are very susceptible to inhibition by PMSF [11, 12] . The illustration is based on the PDB ID 2HA4 crystal structure [6] . The two AChs 5 are positioned above and below the bottleneck residues, Y337 and Y124, which are displayed as sticks, with magenta dots displaying their full space-filling surface; the surface of the gorge as a whole is displayed in grey.
In an earlier study, we reported that AChE from the electric organ of another electric fish, Torpedo californica (Tc) AChE, is also resistant to PMSF, but is irreversibly inhibited very effectively by its homolog benzenesulfonyl fluoride (BSF) (Scheme 1) [13] . In contrast, we found that mouse AChE (mAChE) is very well inhibited by both PMSF and BSF. These observations are puzzling because the crystal structures of TcAChE [4] and mAChE [14] are very similar (Fig 2) , as are the kinetic constants for their extremely rapid action on their natural substrate, ACh, and on its homolog, acetylthiocholine [15, 16] . We subsequently reported that the anti-Alzheimer drug, rivastigmine (Exelon™), carbamylates human AChE >1,600-fold faster than TcAChE [17] . In the following we present theoretical evidence, using rigid docking in tandem with molecular dynamics (MD) simulations, which shows that differences in flexibility of TcAChE and mammalian AChEs can account for the striking differences experimentally observed in their rates of inhibition by both sulfonylating and carbamylating agents [13, 17, 18] . Thus, reliance on docking data alone in the context of drug design has the potential to produce very misleading results. The overall structures of the two enzymes closely resemble each other, with RMSD values of C atoms 0.54 Å for 449 atoms after protein preparation, and 0.54 Å, for 434 atoms, for the RSCB pdb structures. However, careful inspection reveals three clear differences between the TcAChE and mAChE structures:
Results:

Structural Comparison of TcAChE and mAChE.
(i) There is a difference in one residue at the bottleneck of the active-site gorge, F330 in TcAChE being replaced by Y337 in mAChE, with the sidechains of these two residues being oriented very differently ( Fig 3) .
(ii) In mAChE there are four residues, P258-P259-G260-G261, which are absent in TcAChE (Fig 4) . As a result, a significantly larger loop protrudes in mAChE than in TcAChE ( Fig 5) .
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(iii) In addition to the bottleneck residue, four additional residues in the upper portion of the gorge differ in TcAChE and mAChE: E73(T75), Q74(L76), S81(T83), S124(A127). 
MD simulations of TcAChE and mAChE.
Knowledge of the intrinsic flexibility of a protein is important for understanding how structure is linked to function [20] . Accordingly, we performed 20-ns MD simulations on the native crystal structures of TcAChE and mAChE ( Fig 6) . Although the 3D structures are almost identical, the MD simulations clearly reveal that mAChE is significantly more flexible than TcAChE. Our MD simulations are consistent with those previously published for mAChE [21] and for TcAChE [22] 
Docking.
No crystal structures are available of complexes or conjugates of BSF or PMSF with AChE.
Therefore, GlideXP was used to dock both inhibitors into TcAChE [23] and mAChE [24] .
In all four cases, the inhibitors dock at a very similar position (Fig 8) , with the electrophilic sulfur atom remaining at a great distance from the nucleophilic hydroxyl group of S200(S203) within the active site at the bottom of the gorge (Fig 8 and Table 1 ). 
MD Simulation Following Docking.
Since BSF inhibits both TcAChE and mAChE, whereas PMSF inhibits only mAChE, the docking results displayed in the previous section obviously do not reflect the experimental data. We decided, therefore, to perform MD simulations following docking [24, 25] . It can be clearly seen that after the MD simulation BSF approaches close to S200(S203)O in 
Discussion:
As mentioned in the Introduction, TcAChE, mAChE, and human (h) AChE, act at similar rates on their natural substrate, ACh, and on its homolog, ATCh. They have high sequence homology, and their crystal structures reveal almost identical folds. Yet at least two covalent inhibitors interact several orders of magnitude more rapidly with the mammalian enzymes than with TcAChE [13, 17] . It was on this issue that our theoretical study focused.
Since TcAChE and the mammalian enzymes do not differ appreciably in their 3D structures [26] , steric factors do not seem to explain these very large differences. Consequently, we 15 considered the possibility that differences in their dynamics might provide an explanation.
However, it should be kept in mind that, whereas BSF has a planar geometry (Scheme 1), PMSF has a non-planar geometry due to the presence of the additional methylene group, so that its movement through the bottleneck might be expected to be more restricted than that of BSF. It should be noted that in all cases, after docking alone both PMSF and BSF were oriented with their sulfonyl moiety pointing up the gorge, away from the active site. But when docking was followed by the MD protocol, in all cases the molecule flipped ~180°, so that the sulfonyl moiety pointed towards the active-site S200(S203)O. This was true also for PMSF interacting with TcAChE, even though in this case the ligand did not cross the bottleneck. In the crystal structure of S203A mAChE referred to in the Introduction (PDB ID 2HA4) [6] two copies of the substrate, ACh, are seen, one below the bottleneck, and one trapped above it. That trapped above it is oriented, like PMSF and BSF after docking followed by MD simulation, with its leaving group facing into the bottleneck, and its quaternary group making a -cation interaction with W286 in the peripheral anionic site.
Experimental mutagenesis studies that we performed earlier also suggested that breathing motions might be involved in controlling access of PMSF to the active site. The double mutation, F288L/F290V, which enlarges the acyl pocket, thus permitting TcAChE to act on butyrylthiocholine [27], renders it even more susceptible to PMSF than the WT enzyme [13] . Furthermore, the L282A mutation, which has lower thermal stability than the WT enzyme [28] , is inactivated by PMSF at a rate similar to that at which it inactivates the F288L/F290V mutant [13, 29] . Thus, in several cases increased flexibility of AChE appears to be associated with the capacity to be inhibited by PMSF.
As mentioned in the Introduction, the carbamylating agent, rivastigmine, inactivates hAChE (which is highly homologous to mAChE, even more so than TcAChE) three orders of magnitude faster than it inactivates TcAChE [17] . However, various organophosphates (OPs) do not display such differences in rates of phosphorylation of TcAChE and hAChE.
Thus, the rates of inactivation of TcAChE and hAChE by diisopropylphosphorofluoridate (DFP) are quite similar [30] , and the potent S isomers of VX and Russian VX actually inactivate TcAChE a few-fold faster than hAChE (Y. Ashani, personal communication).
Another interesting case for comparison is that of (-)-huperzine A (HupA). This is a bulky alkaloid with a rigid structure and diameter of 9.8 Å. Although HupA is a reversible inhibitor, it inhibits AChE with extremely slow rates of association and disassociation [31] .
MD and steered MD simulations show that sizeable distortions of the residues along the active-site gorge are required for it to pass the bottleneck [32] [33] [34] . Yet the rates of inhibition of TcAChE and hAChE by HupA are very similar [31] . It is obvious that our understanding of how protein function is coupled to protein dynamics is inadequate, to say the least. 
Methods
Protein Preparation for Docking and Molecular Dynamics: The 1EA5 and 5DTI
structures were prepared with Protein Preparation Wizard [38, 39] in Maestro-v11.1 [40] prior to grid-based-ligand docking (GLIDE) [41, 42] and MD studies, with the following modifications:
• All waters and cofactors were removed. Ligand preparation: Geometries of the two inhibitors, BSF and PMSF, were optimized using the PBE0 hybrid density functional method [44, 45] combined with the cc-pVTZ Gaussian basis set [46] . Calculations were performed with water as the solvent, using the SCRF continuum solvation model [47] . All calculations utilized the Gaussian 09 suite [48] .
The parameters of BSF and PMSF were assigned using the OPLS3 force field [43] with the LigPrep [49] tool available in the Schrödinger suite. One hundred poses were generated per docking calculation. In order to soften the potential for non-polar atoms of the protein (within the grid points) and the ligands, their VDW radii were scaled to 1.0 Å, with a partial charge cut-off of 0.25 units, while VDW radii of remaining atoms were not scaled (see S7 Fig in Supplementary Information) . Glide docking uses a hierarchical clustering algorithm to produce the best set of ligand-binding locations in the defined receptor grid space. The lowest XP glide score, for a given ligand, indicates the highest binding affinity for the enzyme.
Molecular Dynamics Simulations.
The Desmond-v4.9 [51] simulation package from Schrödinger was used for all MD simulations. The protein-ligand complex systems were solvated using the explicit SPC [52] solvent model in a 10x10x10Å box, employing the OPLS3 force field [43] ( 
